InVivo BioTech Services GmbH is a leading German contract manufacturing organization (CMO) specializing in the in vitro production of monoclonal antibodies and recombinant proteins, with expertise in mammalian and bacterial transient expression systems.
Headquartered on the biotech campus in Hennigsdorf, with additional facilities in Berlin, InVivo has over two decades of experience serving diverse clients, from university spin-offs to major research institutes and biopharmaceutical companies. As an ISO 9001-certified organization, InVivo offers a complete suite of biotech services, from cell line development and immunoassay creation to large-scale antibody production. Since joining the Bruker Corporation in 2017, InVivo has continued to innovate and expand its service offerings to meet the complex needs of the biomedical and diagnostic industries.
Portfolio
- Monoclonal antibodies from mouse hybridoma
- Recombinant antibodies expressed in HEK or CHO
- In vivo antibodies & isotype controls
- Proteins
- SARS CoV-2 Antigens und Antibodies
Monoclonal antibodies
InVivo BioTech Services GmbH provides an extensive catalog of high-quality monoclonal antibodies from mouse hybridoma. These antibodies are produced with high specificity and purity, optimized for diagnostic and research applications in various biomedical fields.
Bestsellers
| Cat-No. | Item | Size | Price (CHF) |
|---|---|---|---|
| RP_003-1MG | Human NT-ProBNP | 1 mg | 2'005.00 |
| RP_177-1MG | TEV-Protease | 1 mg | 520.00 |
| AK1146-1MG | Anti CA15-3 | 1 mg | 1'785.00 |
| AK2668-1MG | Anti Procalcitonin (PCT) | 1 mg | 1'895.00 |
| RP_SZ_361-1MG | Human IgE | 1 mg | 1'455.00 |
Services
InVivo Biotech Services offer cost-effective solutions for in vitro production of monoclonal antibodies and recombinant proteins, transient expression in mammalian and bacterial systems, cell line development, and immunassay development.
